date:Apr 25, 2013
arious options, but he declined to say if the division might be sold off at a later stage.
Jefferies analysts, however, said the formation of the portfolio looks like a precursor to a spin-off to us.
GSK's group sales in the first quarter fell 3 percent to 6.47 billion pounds, generating flat core earnings per share (EPS) of 26.9 pence.
Analysts, on average, had forecast sales of 6.40 billion pounds and core EPS, which excludes certain items, of 25.0p, according to Thomson Reuters I/B/E/S.
T